Do Pharma’s Claims On Drug Prices Pass The Smell Test? We Found 5 Stinkers

Drug companies launched an ad and publicity extravaganza this year right after President-elect Donald Trump said they “are getting away with murder” on sky-high pill prices.

Read More

Other States Closely Watching Fate of California’s Drug Price Transparency Bill

Insurers, hospitals and health advocates are waiting for Gov. Jerry Brown to deal the drug lobby a rare defeat, by signing legislation that would force pharmaceutical companies to justify big price hikes on drugs in California.

Read More

Price Resignation Sets Off Frenzy of Speculation Over Replacement

The resignation of embattled Health and Human Services Secretary Tom Price for using private jets for government travel is setting off a frenzy of speculation about who will replace him.

Read More

Why Medi-Cal Enrollees Gain Coverage But Not Broad Access To Doctors

Medi-Cal enrollee Michael Gonzalez worked for months in 2015 to get to the Sutter specialists who ultimately treated his thyroid cancer, so he felt undermined this summer when Sutter Health announced that its primary-care doctors would no longer be serving 10,000 adult patients in Sacramento and Placer counties.

Read More

FDA Chief Says Agency Will Take Action To Lower Drug Prices

The Food and Drug Administration (FDA) will take action to deal with the rising cost of prescription drugs, the agency’s head said on Monday.

Read More

Zenefits to Exit BOR Business, Work With Agencies to License its Technology

The San Francisco-based firm’s existing book of 7,000 accounts will be transferred to OneDigital, an Atlanta-based brokerage, as Zenefits undergoes a transformation “to embracing the broker community and partnering with them in a pretty significant way,” Zenefits Chairman and CEO Jay Fulcher says.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square